<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel rdf:about="http://hdl.handle.net/20.500.12701/1984">
    <title>DSpace Собрание: Brain Sciences is an international, peer-reviewed, open access journal on neuroscience, published monthly online by MDPI.</title>
    <link>http://hdl.handle.net/20.500.12701/1984</link>
    <description>Brain Sciences is an international, peer-reviewed, open access journal on neuroscience, published monthly online by MDPI.</description>
    <items>
      <rdf:Seq>
        <rdf:li rdf:resource="http://hdl.handle.net/20.500.12701/1985" />
      </rdf:Seq>
    </items>
    <dc:date>2024-02-21T19:55:40Z</dc:date>
  </channel>
  <item rdf:about="http://hdl.handle.net/20.500.12701/1985">
    <title>Serum BDNF’s Role as a Biomarker for Motor Training in the Context of AR-Based Rehabilitation after Ischemic Stroke</title>
    <link>http://hdl.handle.net/20.500.12701/1985</link>
    <description>Название: Serum BDNF’s Role as a Biomarker for Motor Training in the Context of AR-Based Rehabilitation after Ischemic Stroke
Авторы: Koroleva, Ekaterina S.; Tolmachev, Ivan V.; Alifirova, Valentina M.; Boiko, Anastasiia S.; Levchuk, Lyudmila A.; Loonen, Anton J. M.; Ivanova, Svetlana A.
Краткий осмотр (реферат): Background: brain-derived neurotrophic factor (BDNF) may play a role during neurorehabilitation following ischemic stroke. This study aimed to elucidate the possible role of BDNF during early recovery from ischemic stroke assisted by motor training. Methods: fifty patients were included after acute recovery from ischemic stroke: 21 first received classical rehabilitation followed by ‘motor rehabilitation using motion sensors and augmented reality’ (AR-rehabilitation), 14 only received AR-rehabilitation, and 15 were only observed. Serum BDNF levels were measured on the first day of stroke, on the 14th day, before AR-based rehabilitation (median, 45th day), and after the AR-based rehabilitation (median, 82nd day). Motor impairment was quantified clinically using the Fugl–Meyer scale (FMA); functional disability and activities of daily living (ADL) were measured using the Modified Rankin Scale (mRS). For comparison, serum BDNF was measured in 50 healthy individuals. Results: BDNF levels were found to significantly increase during the phase with AR-based rehabilitation. The pattern of the sequentially measured BDNF levels was similar in the treated patients. Untreated patients had significantly lower BDNF levels at the endpoint. Conclusions: the fluctuations of BDNF levels are not consistently related to motor improvement but seem to react to active treatment. Without active rehabilitation treatment, BDNF tends to decrease.</description>
    <dc:date>2020-09-09T00:00:00Z</dc:date>
  </item>
</rdf:RDF>

